# Martin Köbel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martin-kobel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,679 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 79 |
| i10-index | 215 |
| Last Known Institution | University of Calgary |
| OpenAlex ID | https://openalex.org/A5086449500 |
| ORCID iD | https://orcid.org/0000-0002-6615-2037 |
| Works | 584 |

## Researcher papers

- [Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary](https://scholariq.org/papers/mutation-of-i-foxl2-i-in-granulosa-cell-tumors-of-the-ovary/)
- [Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study](https://scholariq.org/papers/hormone-receptor-expression-and-ovarian-cancer-survival-an-ovarian-tumor-tissue/)
- [Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer](https://scholariq.org/papers/dose-response-association-of-cd8-sup-sup-tumor-infiltrating-lymphocytes-and/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Chromatin Remodeling and Cancer](https://scholariq.org/topics/chromatin-remodeling-and-cancer/)

## Researcher university

- [University of Calgary](https://scholariq.org/institutions/university-of-calgary/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.